IRIS
AQUARO, Stefano
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.330
AS - Asia 6.084
EU - Europa 3.534
SA - Sud America 2.005
AF - Africa 387
Continente sconosciuto - Info sul continente non disponibili 103
OC - Oceania 9
AN - Antartide 1
Totale 21.453
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.930
SG - Singapore 2.519
BR - Brasile 1.494
UA - Ucraina 1.265
VN - Vietnam 1.126
CN - Cina 1.017
DE - Germania 689
IT - Italia 518
FR - Francia 290
SE - Svezia 270
BD - Bangladesh 248
TR - Turchia 215
CA - Canada 199
HK - Hong Kong 188
AR - Argentina 180
KR - Corea 156
SN - Senegal 115
IN - India 112
EC - Ecuador 102
AT - Austria 97
RU - Federazione Russa 87
FI - Finlandia 85
MX - Messico 79
IQ - Iraq 78
ZA - Sudafrica 78
ID - Indonesia 71
CO - Colombia 55
PK - Pakistan 51
GB - Regno Unito 50
VE - Venezuela 45
CL - Cile 40
UZ - Uzbekistan 38
MA - Marocco 36
PY - Paraguay 33
TN - Tunisia 30
MY - Malesia 29
BE - Belgio 27
KE - Kenya 27
DZ - Algeria 26
UY - Uruguay 26
PL - Polonia 21
SA - Arabia Saudita 21
KZ - Kazakistan 20
CR - Costa Rica 19
EG - Egitto 19
ES - Italia 19
NL - Olanda 19
JP - Giappone 18
AL - Albania 17
JO - Giordania 17
NI - Nicaragua 17
ET - Etiopia 16
NP - Nepal 16
PE - Perù 16
PH - Filippine 16
AE - Emirati Arabi Uniti 15
RO - Romania 15
HN - Honduras 14
OM - Oman 14
BO - Bolivia 12
GT - Guatemala 12
LB - Libano 12
PA - Panama 12
AZ - Azerbaigian 11
JM - Giamaica 11
PS - Palestinian Territory 11
EU - Europa 10
PR - Porto Rico 9
IE - Irlanda 8
SV - El Salvador 8
TT - Trinidad e Tobago 8
BY - Bielorussia 7
GE - Georgia 7
NG - Nigeria 7
SY - Repubblica araba siriana 7
AU - Australia 6
CZ - Repubblica Ceca 6
DO - Repubblica Dominicana 6
IL - Israele 6
LV - Lettonia 6
AO - Angola 5
GA - Gabon 5
IR - Iran 5
KG - Kirghizistan 5
QA - Qatar 5
RS - Serbia 5
DK - Danimarca 4
GP - Guadalupe 4
GR - Grecia 4
KW - Kuwait 4
LK - Sri Lanka 4
MD - Moldavia 4
TZ - Tanzania 4
BH - Bahrain 3
BN - Brunei Darussalam 3
CI - Costa d'Avorio 3
CW - ???statistics.table.value.countryCode.CW??? 3
LT - Lituania 3
PT - Portogallo 3
SK - Slovacchia (Repubblica Slovacca) 3
Totale 21.311
Salva come PNG Salva come JPEG
Città #
Dallas 1.464
Singapore 945
Jacksonville 866
Council Bluffs 757
Ashburn 729
San Jose 651
Chandler 607
Dearborn 447
Boardman 435
Ho Chi Minh City 392
San Mateo 341
Hanoi 260
Beijing 256
New York 201
Lauterbourg 186
Lawrence 186
Roxbury 182
Izmir 180
Seoul 155
Hefei 142
São Paulo 142
Shanghai 139
Milan 126
Des Moines 118
Dakar 115
Hong Kong 114
Ottawa 114
Cambridge 84
Helsinki 76
Wilmington 67
Ann Arbor 66
Vienna 65
Los Angeles 63
Brooklyn 61
Da Nang 55
Grafing 51
Haiphong 50
Phoenix 49
Ogden 48
Rio de Janeiro 47
Guayaquil 42
Rome 41
Miano 40
Chicago 39
Santa Clara 36
Tashkent 33
Brasília 31
Seattle 31
Inglewood 30
Belo Horizonte 28
Johannesburg 28
Tianjin 28
Quito 27
Rende 26
Baghdad 25
Columbus 25
Biên Hòa 24
Porto Alegre 24
Toronto 24
Atlanta 23
Nairobi 23
Salvador 23
Brussels 22
Curitiba 22
Montevideo 22
Hải Dương 21
Dhaka 20
Guarulhos 20
Munich 20
San Francisco 20
Thái Nguyên 20
Bogotá 19
Charlotte 19
Omaha 19
Buenos Aires 18
Asunción 17
Guangzhou 17
Managua 17
The Dalles 17
Tokyo 17
Amman 16
Cape Town 16
Medellín 16
Ribeirão Preto 16
Amsterdam 15
Boston 15
Moscow 15
Caracas 14
London 14
Orem 14
Santiago 14
Strasbourg 14
Warsaw 14
Chennai 13
Goiânia 13
Kuala Lumpur 13
Montreal 13
North Charleston 13
Bắc Ninh 12
Casablanca 12
Totale 12.312
Salva come PNG Salva come JPEG
Nome #
1,2,3-triazole-TSAO analogues: Synthesis and anti-HIV activity 1.528
Carbazole Derivatives as Antiviral Agents: An Overview 253
CCR5/CXCR4 dual antagonism for the improvement of HIV infection therapy 193
Cachrys spp. from Southern Italy: Phytochemical Characterization and JAK/STAT Signaling Pathway Inhibition 191
Identification of chlorocarbazole derivatives as potential antiviral agents. 189
Progettazione, studio di docking molecolare e sintesi di nuove molecole capaci di interagire con il virus responsabile della SARS-COVID 19. 180
Chloro-1,4-dimethyl-9H-carbazole Derivatives Displaying Anti-HIV Activity 177
Advances in macrophage and dendritic cell biology in HIV-1 infection stress key understudied areas in infection, pathogenesis, and analysis of viral reservoirs. 159
Activity of masked 2’-3’-dideoxynucleoside-monophosphate derivatives against human immunodeficiency virus in resting macrophages 158
Antifungal activity of Cardiospermum halicacabum L. (Sapindaceae) against Trichophyton rubrum occurs through molecular interaction with fungal Hsp90. 156
Antimicrobial properties of the medicinal plant Cardiospermum halicacabum L: new evidence and future perspectives 152
Diarylureas: Repositioning from Antitumor to Antimicrobials or Multi-Target Agents against New Pandemics 152
AZT treatment of HIV-1 infected macrophages prevents apoptosis and necrosis in human astrocytic cells 151
Apoptosis in Human Astrocytic Cells Induced by HIV-Infected Macrophages 151
ANTIBACTERIAL AND ANTIVIRAL PHARMACEUTICAL COMPOSITION 151
COVID-19 at a Glance: An Up-to-Date Overview on Variants, Drug Design and Therapies. 148
Antiretrovirus activity of novel class of acyclic pyrimidine nucleoside phosphonates 146
Anti-HIV efficacy in primary monocyte/macrphage by phosphorylated and phosphonated derivatives of nucleside analogues 146
Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure 142
Activity of GM-CSF and M-CSF upon Replication of HIV and Other DNA- and RNA-Viruses in Primary Macrophages 140
Activity of masked 2’-3’-Dideoxynucleoside Monophosphate Derivatives Against Human Immunodeficiency Virus in Resting Macrophages 139
Analisi mediante PCR dell’influenza di citochine sulla replicazione virale di HIV-1 e HSV-1 in macrofagi primari umani 139
Anti-HIV activity of nucleoside analogues in mononuclear cells. Workshop on Recent advances in modified nucleosides 138
Anti-HIV activity of protease inhibitors in productively-infected macrophages and correlation with clinical outcome 137
Thidiazuron: New Trends and Future Perspectives to Fight Xylella fastidiosa in Olive Trees 136
Anti-nerve growth factor Ab abrogates macrophage mediated HIV-1 infection and depletion of CD4+ T lymphocytes in hu-SCID mice 135
Anti-nerve Growth Factor Antibody Abrogates Macrophages-mediated HIV-1 Infection and Depletion of CD4+ T-lymphocytes in hu-SCID Mice 132
Acyclic nucleoside phosphonates: A new class of compounds with antiviral and immunomodulatory activity 130
Antiviral activity of amprenavir in human macrophages acutely and chronically infected by HIV-1 129
Antibiotic-Resistant ESKAPE Pathogens and COVID-19: The Pandemic beyond the Pandemic. 128
Antibacterial and Anti-Influenza Activities of N-Heterocyclic Carbene–Gold Complexes 124
CARBAZOLE DERIVATIVES TARGETING HUMAN TOPOISOMERASES I AND ACTIN IN BREAST CANCER TREATMENT 122
Antiviral efficacy of inhibitors of HIV protease in chronically-infected macrophages 119
The Ongoing Impact of COVID-19 on Pediatric Obesity 117
The counter-current centrifugal elutriation (cee) as essential tool for purification of monocytes and the assessment of the activity of cytokines upon virus replication 116
When Chirality Makes the Difference: The Case of Novel Enantiopure N-Heterocyclic Carbene–Gold and –Silver Complexes 116
Cytokines in HIV infection 115
Activity of the (R)-Enantiomers of 9-(2-phosphonylmethoxypropyl)-adenine [(R)-PMPA] and 9-(2-phosphonylmethoxypropyl)-2,6-diaminopurine [(R)-PMPDAP] against Human Immunodeficiency Virus in Different Human Cell Systems 114
Potent antiviral activity of amprenavir in primary macrophages infected by human immunodeficiency virus 112
Impact of Cytochrome P450 Enzymes on the Phase I Metabolism of Drugs 110
Glutathione inhibits HIV replication by acting at late stages of virus lifecycle 109
Inhibition of human immunodeficiency virus (HIV-1) infection in human peripheral blood leucocytes-SCID reconstituted mice by rapamycin 108
M40401, a sod mimetic compound with a potent anti-HIV activity in macrophages, prevents apoptosis in astrocytes 108
Understanding HIV compartments and reservoirs. 107
Factors affecting the anti-HIV and anti-HSV activity of nucleoside analogues in macrophages 107
Antiviral activity of nucleoside analogues in macrophages 107
Triclosan: A Small Molecule with Controversial Roles 106
Il macrofago e l’infezione da HIV. Ruolo delle cellule lungo sopravviventi nella patogenesi e nella terapia. 106
Microbiological Characteristics and Physico-chemical Parameters of Fermented Milk Product Ergo-A Traditional Yogurt Product of Ethiopia 106
New Therapies and Strategies to Curb HIV Infections with a Focus on Macrophages and Reservoirs 104
Therapeutic strategies towards HIV-1 infection in macrophages 104
Development of HIV mutations in human primary macrophages under RT inhibitors treatment does non confer drug resistance 104
TAK-779 blocca il corecettore CCR5 ed inibisce fortemente la replicazione di ceppi monocitotropi di HIV, in vitro ed in vivo 104
Silver and Gold Complexes with NHC-Ligands Derived from Caffeine: Catalytic and Pharmacological Activity 104
Does residual virus replication during successful HAART lead to HIV-1 genetic evolution? 103
Inhibition of the protease of human immunodeficiency virus blocks replication and infectivity of the virus in chronically-infected macrophages 103
Studio di fattori che influenzano l’attivita’ anti-HIV ed anti-HSV di analoghi nucleosidici nei monociti-macrofagi 103
Ru-NHC complexes with a broad spectrum of biological activities. 102
Identification of Pinosylvin in Pinus nigra subsp. laricio: A Naturally Occurring Stilbenoid Suppressing LPS-Induced Expression of Pro-Inflammatory Cytokines and Mediators and Inhibiting the JAK/STAT Signaling Pathway 102
Macrofagi infettati da HIV provocano in vitro morte cellulare per apoptosi in cellule astrocitarie 102
S-adenosylhomocysteine hydrolase inhibitors interfere with the replication of human immunodeficiency virus type 1 through inhibition of the LTR transactivation 102
Conversion of 2',3'-dideoxyadenosine (ddA) and 2',3'-didehydro-2',3'-dideoxyadenosine (d4A) to their corresponding aryloxyphosphoramidate derivatives markedly potentiates their activity against human immunodeficiency virus and hepatitis B virus 101
Mechanism of anti-HIV action of masked alaninyl d4T-MP derivatives 101
The degree of HIV-1 amino acid variability is strictly related to different disease progression rates 101
Enhancing the Anticancer and Anti-Inflammatory Properties of Curcumin in Combination with Quercetin, for the Prevention and Treatment of Prostate Cancer 100
Nerve growth factor in an autocrine factor essential for the survival of macrophages infected by human immunodeficiency virus 100
Potente efficacia anti-HIV di LD 78 β isoforma di MIP-1α, in monociti e macrofagi umani 100
Are Nutraceuticals Effective in COVID‐19 and Post‐COVID Prevention and Treatment? 99
Macrophages and HIV infection: therapeutical approaches toward this strategic virus reservoir 99
oxidative stress and HIV infection:target pathways for novel therapies? 99
Modulazione dell’infezione da virus influenzale in macrofagi trattati con citochine 99
Attivita’ di farmaci inibitori del virus dell’immunodeficienza umana in macrofagi umani e correlazione con l’efficacia clinica 97
Le mutazioni osservate nei macrofagi primari umani dopo trattamento con farmaci inibitori della transcrittasi inversa non conferiscono resistenza 97
Effects of Amprenavir on HIV-1 Maturation, Production and Infectivity Following Drug Withdrawal in Chronically-Infected Monocytes/Macrophages 97
A Hyper-Glycosylation of HBV Surface Antigen Correlates with HBsAg-Negativity at Immunosuppression-Driven HBV Reactivation in Vivo and Hinders HBsAg Recognition in Vitro 97
Relative potency of protease inhibitors in monocytes/macrophages acutely and chronically infected with human immunodeficiency virus 96
Inhibition of human immunodeficiency virus replication by a dual CCR5/CXCR4 antagonist 96
Influenza virus A (H5N1): a pandemic risk? 95
Potent anti-HSV effect of HPMPC in resting macrophages 95
M40401, un composto sod-mimetico con potente attività anti-HIV nei macrofagi, previene l’apoptosi negli astrociti 95
Le basi razionali della terapia di associazione nel trattamento dell’AIDS 94
The contribution of oxidative stress in apoptosis of human-cultured astroglial cells induced by supernatants of HIV-1-infected macrophages 94
Cyclosaligenil-2’,3’-didehydro-2’,3’ – dideoxythymidine Monophosphate: efficient Intracellular Delivery of d4TMP 94
Limited development and progression of resistance of HIV-1 to the nucleoside analogue reverse transcriptase inhibitor lamivudine in human primary macrophages 94
Razionale della terapia dell’encefalopatia da HIV-1: inibizione della replicazione virale in macrofagi 94
Chirality influences the biological properties of novel NHC-gold and -silver complexes 92
Comparative antiviral activity of integrase inhibitors in human monocyte-derived macrophages and lymphocytes 92
Antiviral Profile of HIV Inhibitors in Macrophages: Implications for Therapy 92
Phylogenetic analysis of the surface proteins of influenza A (H5N1) viruses isolated in Asian and African populations 92
Dinamica virale nei reservoirs. Infezioni da HIV: approfondimenti sul tema 92
Attività anti-HIV di differenti classi di farmaci antivirali di interesse clinico: valutazione in vitro dell’efficacia in monociti/macrofagi primari e linfociti 92
GM-CSF and M-CSF modulate the replication of HIV and other viruses in primary macrophages by acting on different steps of virus lifecycle 92
Different Patterns of HIV-1 Replication in MACROPHAGES is Led by Co-Receptor Usage 92
N-Heterocyclic Carbene-Gold(I) Complexes Targeting Actin Polymerization 92
Identification of gp120 polymorphisms in HIV-1 B subtype potentially associated with resistance to fostemsavir 91
Phosphorylated and phosphonated derivatives of nucleoside analogues are more active against HIV in monocyte/macrophages than in lymphocytes 90
The Potent Inhibition of Human Immunodeficiency Virus and Herpes Simplex Virus Type 1 by 9-(2-Phosphonylmethoxyethyl)Adenine (PMEA) in Primary Macrophages Is Determined by Drug Metabolism, Nucleotide Pools and Cytokines 90
Multidrug Resistance (MDR): A Widespread Phenomenon in Pharmacological Therapies 90
Highly Favorable antiviral activity and resistance profile of the novel thiocarboxanilide pentenyloxy ether derivatives UC-781 and UC-82 as inhibitors of human immunodeficiency virus type 1 (HIV-1) replication 89
Mechanisms underlying activity of antiretroviral drugs in HIV-1-infected macrophages: new therapeutic strategies. 88
Totale 13.072
Salva come PNG Salva come JPEG
Categoria #
all - tutte 116.310
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 116.310
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.365 0 0 0 112 139 61 12 405 34 9 201 392
2022/20231.536 224 110 51 182 155 134 2 221 236 47 112 62
2023/2024888 88 25 56 27 48 172 22 35 108 30 47 230
2024/20252.354 141 458 52 93 129 107 72 130 429 134 201 408
2025/20269.757 1.161 575 1.607 1.156 1.725 453 922 423 414 629 276 416
2026/20271.884 486 78 384 936 0 0 0 0 0 0 0 0
Totale 21.453